Safety of Tetravalent Conjugate Meningococcal Vaccine (Serotypes A, C, Y, W) for 1–4 Years Old Children With Distresses and Chronic Diseases in Closed Healthcare Facility: Cohort Study

Background. Tolerance to immunization with conjugate tetravalent vaccine against meningococcal infection (serotypes A, C, Y, W) for vulnerable categories of children has not been studied before. The aim of the study is to estimate the safety of the conjugate tetravalent vaccine against meningococcal...

Full description

Bibliographic Details
Main Authors: Alebai U. Sabitov, Mariya V. Frajfeld
Format: Article
Language:English
Published: Paediatrician Publishers, LLC 2019-12-01
Series:Pediatričeskaâ Farmakologiâ
Subjects:
imd
Online Access:https://www.pedpharma.ru/jour/article/view/1759